Formulation Development and Evaluation Technique for Immediate and Modified Release Capsule

Year : 2025 | Volume : 03 | Issue : 01 | Page : 1 9
    By

    Mohd. Wasiullah,

  • Piyush Yadav,

  • Deepak Kumar Yadav,

  • Vinay Kumar Yadav,

  1. Principal, Department of Pharmacy, Prasad Institute Technology, Jaunpur, Uttar Pradesh, India
  2. Academic Head, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  3. Lecturer, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India
  4. Student, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, Uttar Pradesh, India

Abstract

The development and evaluation of formulations for immediate-release (IR) and modified-release (MR) capsules represent a critical aspect of pharmaceutical dosage form design, offering distinct advantages in terms of drug release profiles and therapeutic outcomes. This study focuses on the formulation strategies, techniques, and evaluation methods used to develop both IR and MR capsules. Immediate-release capsules are designed to disintegrate quickly in the gastrointestinal tract, ensuring rapid drug absorption, while modified-release capsules are engineered to control the release of the active pharmaceutical ingredient (API) over an extended period or at specific sites within the digestive system. For the IR capsules, the formulation development process typically involves the selection of suitable excipients, such as disintegrants, fillers, and lubricants, to achieve rapid dissolution. In contrast, MR capsules often incorporate rate-controlling mechanisms, such as polymers, coatings, or matrix systems, which allow for sustained or delayed release. The evaluation of both types of capsules is carried out through a combination of in vitro tests including dissolution testing, disintegration time, and stability studies, alongside in vivo bioavailability studies to assess the therapeutic efficacy and safety of the drug.

Keywords: Modified release, capsule formation, drug delivery, polymers, pharmaceutical excipients

[This article belongs to International Journal of Biochemistry and Biomolecule Research ]

How to cite this article:
Mohd. Wasiullah, Piyush Yadav, Deepak Kumar Yadav, Vinay Kumar Yadav. Formulation Development and Evaluation Technique for Immediate and Modified Release Capsule. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):1-9.
How to cite this URL:
Mohd. Wasiullah, Piyush Yadav, Deepak Kumar Yadav, Vinay Kumar Yadav. Formulation Development and Evaluation Technique for Immediate and Modified Release Capsule. International Journal of Biochemistry and Biomolecule Research. 2025; 03(01):1-9. Available from: https://journals.stmjournals.com/ijbbr/article=2025/view=198198


Browse Figures

References

  1. Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6):e17488.
  2. Park H, Otte A, Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. J Control Release. 2022;342:53–65.
  3. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
  4. Tanwar H, Sachdeva R. Transdermal drug delivery system: A review. Int J Pharm Sci Res. 2016;7(6):2274.
  5. Gupta P, Gnanarajan PK, Kothiyal P. Floating drug delivery system: a review. Int J Pharma Res Rev. 2015;4(8):37–44.
  6. Gaikwad SS, Ainor SK, Lande NB, Salunkhe KS. Review of modified oral solid drug delivery system and recent active patents. Appl Drug Res Clin Trials Regulatory Affairs. 2022;9(1):20–29.
  7. Sharma A, Saini S, Rana AC. Transdermal drug delivery system: a review. Int J Res Pharm Biomed Sci. 2013;4(1):286–292.
  8. Dhiman S, Singh TG, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011;3(5):26–34.
  9. Mali AD. An updated review on transdermal drug delivery systems. Skin. 2015;8(9):244–254.
  10. Parivesh S, Sumeet D, Abhishek D. Design, evaluation, parameters and marketed products of transdermal patches: A review. J Pharm Res. 2010;3(2):235–240.
  11. Saroha K, Yadav B, Sharma B. Transdermal patch: A discrete dosage form. Int J Curr Pharm Res. 2011;3(3):98–108.
  12. Kumar A, Machhindra KS, Jain K, Yadav AK. Transdermal drug delivery system. Novel Carrier Systems for Targeted and Controlled Drug Delivery. Singapore: Springer Nature Singapore; 2024. 115–133.
  13. Alkilani AZ, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H, et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics. 2022;14(6):1152.
  14. Bhowmik D, Pusupoleti KR, Duraivel S, Kumar KS. Recent approaches in transdermal drug delivery system. Pharm Innov. 2013;2(3, Part A):99.
  15. Bala P, Jathar S, Kale S, Pal K. Transdermal drug delivery system (TDDS)-a multifaceted approach for drug delivery. J Pharm Res. 2014;8(12):1805–1835.
  16. Yadav V. Transdermal drug delivery system. Int J Pharm Sci Res. 2012;3(2):376.
  17. Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! J Control Release. 2014;190:150–156.
  18. Kaestli LZ, Wasilewski-Rasca AF, Bonnabry P, Vogt-Ferrier N. Use of transdermal drug formulations in the elderly. Drugs Aging. 2008;25:269–280.
  19. Guy RH. Transdermal drug delivery. Drug Deliv. 2010:399–410.
  20. Sadeghi F, et al. Modified release formulations: development and evaluation techniques. J Control Release. 2017;260:40–51.
  21. Venkatesh DK, et al. Development of controlled release formulations of poory soluble drugs. Drug Devel Ind Pharm. 2011;37(10):1214–1220.
  22. Singh SP, et al. Formulation and evaluation of modified release capsules for the treatment of chronic conditions. Int J Pharm Sci. 2018;10(5):376–386.
  23. Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187.
  24. Bird D, Ravindra NM. Transdermal drug delivery and patches—An overview. Med Devices Sens. 2020;3(6):e10069.
  25. Rizwan M, Aqil M, Talegaonkar S, Azeem A, Sultana Y, Ali A. Enhanced transdermal drug delivery techniques: an extensive review of patents. Recent Patents Drug deliv Formul. 2009;3(2):105–124.
  26. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115–124.
  27. Sabbagh F, Kim BS. Recent advances in polymeric transdermal drug delivery systems. J Control Release. 2022;341:132–146.
  28. Alam MI, Alam N, Singh V, Alam MS, Ali MS, Anwer T, et al. Type, preparation and evaluation of transdermal patch: a review. World J Pharm and Pharm Sciences. 2013;2(4):2199–2233.
  29. Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9(16):697–703.
  30. Rastogi V, Yadav P. Transdermal drug delivery system: An overview. Asian J Pharma (AJP). 2012;6(3).
  31. Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: A review. Biomater Res. 2021;25(1):24.
  32. Cross SE, Roberts MS. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv. 2004;1(1):81–92.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 14/12/2024
Accepted 21/12/2024
Published 13/02/2025
Publication Time 61 Days
379

Login


My IP

PlumX Metrics